Status:
ACTIVE_NOT_RECRUITING
Holter of Movement in Patients with SMA Undergoing Treatment.
Lead Sponsor:
Centre Hospitalier Universitaire de Liege
Collaborating Sponsors:
SYSNAV
Erasme University Hospital
Conditions:
Spinal Muscular Atrophy
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
Acti-SMA is a multi-centric academic study. It aims to monitor the progress of patients with spinal muscular atrophy under treatment with Spinraza° or risdiplam. First, we want to quantify improvement...
Eligibility Criteria
Inclusion
- Genetically confirmed spinal muscular atrophy.
- Treatment by Spinraza ° or by risdiplam planned.
- Over 6 years old.
- Signed informed consent.
Exclusion
- \- Patients with excessive cognitive disorders, limiting the understanding of task or with apparent communication difficulties hindering data collection.
Key Trial Info
Start Date :
August 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04888702
Start Date
August 8 2018
End Date
May 30 2025
Last Update
February 12 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Régional de la Citadelle
Liège, Liège, Belgium, 4000
2
Erasme Hospital - Cliniques universitaires de Bruxelles
Brussels, Belgium, 1000
3
National Clinical Hospital for Children Neurohabilitation "Dr Nicolae Robanescu"
Bucharest, Romania